ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of HLA Antibody Surveillance Protocol in Heart Transplant Patients – A Single-Center Retrospective Analysis

S. S. Patlolla, V. Bhattad, S. McKean, M. Askar, S. Hall

Baylor University Medical Center, Dallas, TX

Meeting: 2021 American Transplant Congress

Abstract number: 1189

Keywords: Heart transplant patients, HLA antibodies, Rejection, Survival

Topic: Clinical Science » Heart » Heart and VADs: All Topics

Session Information

Session Name: Heart and VADs: All Topics

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Post-transplant care is multifaceted with protocols to provide oversight and maintain the standard of care. While institutional protocols for post-transplant HLA antibody surveillance after a positive virtual crossmatch (VXM) are often implemented, the impact on outcomes and survival is unclear. Our program implemented a protocol for antibody mediated rejection (AMR) surveillance for HLA donor specific antibodies (DSA) on post-transplant day 3 and 7 for patients with positive retrospective flow crossmatch (FXM), positive virtual crossmatch (VXM), DSAs present on VXM within 3 months, or DSAs newly detected on the serum sample tested for FXM.

*Methods: Patients who received cardiac transplant between January 2018 and September 2020 in our center were retrospectively reviewed. Data was compiled to evaluate our protocol for DSA surveillance and survival at one-year post transplant. Multi-organ and re-transplant patients were excluded from the study.

*Results: Of 143 eligible patients, 38 (27%) were positive for DSA at VXM. Of the 105 patients with negative VXM, 9 tested positive for DSA on sample used for FXM. Of those negative for DSAs on either crossmatch, only 8% developed DSAs by days 3 and 15% by day 7. Of those with DSAs on either crossmatch, 38% remained positive on days 3 and 7. Out of these patients, one was positive at day 3 with MFI increasing on day 7. Treatment for AMR was initiated on day 8. Only 18% of initially positive patients remained positive at 1 year. 21% were treated for rejection despite only 3% showing biopsy evidence of rejection. At 1 year, 91% of positive patients were alive.

*Conclusions: Our findings suggest that patients positive for DSAs do not have inferior short-term outcomes compared to those negative for DSAs when early and serial HLA antibody testing was performed. This protocol allows early detection of DSAs and prompt management of potential rejection which could improve overall survival.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Patlolla SS, Bhattad V, McKean S, Askar M, Hall S. Outcomes of HLA Antibody Surveillance Protocol in Heart Transplant Patients – A Single-Center Retrospective Analysis [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-hla-antibody-surveillance-protocol-in-heart-transplant-patients-a-single-center-retrospective-analysis/. Accessed June 5, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences